Stocks › IDXX

IDEXX LABORATORIES INC /DE

IDXX·Nasdaq·United States United States·USD
$676.21
-13.44 (-1.95%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
IDXX
IDEXX LABORATORIES INC /DE · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
IDXXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of IDXX by members of U.S. Congress · 121 on record · 17 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$15,001 - $50,000
Nov 5, 2026 Oct 7, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Purchase
$1,001 - $15,000
Oct 8, 2026 Sep 25, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Oct 8, 2026 Sep 4, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$15,001 - $50,000
Oct 8, 2026 Sep 11, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · CMN Purchase
$1,001 - $15,000
Sep 5, 2026 Aug 3, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$1,001 - $15,000
Jun 10, 2026 May 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 15, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 1, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$1,001 - $15,000
May 11, 2026 Apr 13, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$15,001 - $50,000
Apr 7, 2026 Mar 30, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$1,001 - $15,000
Mar 9, 2026 Feb 24, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 17, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Feb 6, 2026 Jan 23, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$15,001 - $50,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Feb 2, 2026 Jan 13, 2026 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Jan 5, 2026 Dec 2, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$1,001 - $15,000
Nov 6, 2025 Oct 7, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Nov 4, 2025 Oct 16, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Nov 4, 2025 Oct 29, 2025 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL IDXXIDEXX LABORATORIES INC /DE · Stock Purchase
$1,001 - $15,000
Oct 7, 2025 Sep 4, 2025 Filing ↗
Byron DonaldsByron DonaldsHouse · R · FL IDXXIDEXX LABORATORIES INC /DE · Stock Purchase
$1,001 - $15,000
Oct 7, 2025 Sep 4, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Stock Purchase
$1,001 - $15,000
Oct 3, 2025 Sep 5, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA IDXXIDEXX LABORATORIES INC /DE · Common Stock Purchase
$1,001 - $15,000
Sep 9, 2025 Aug 4, 2025 Filing ↗
April McClain DelaneyApril McClain DelaneyHouse · D · MD IDXXIDEXX LABORATORIES INC /DE · Stock Sale
$1,001 - $15,000
Sep 2, 2025 Aug 7, 2025 Filing ↗

Whale Activity

Position changes in IDXX reported for 2026-09-30 by 1385 institutional filers
Increased: 392New: 92Held: 211Decreased: 531Closed: 104No prior filing: 55
  • Increased392
  • New92
  • Held211
  • Decreased531
  • Closed104
  • No prior filing55
FilerSharesValueChange
BlackRock, Inc.8.1M$4.23Bdecreased
VANGUARD CAPITAL MANAGEMENT LLC5.2M$2.69Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC4.0M$2.07Bincreased
STATE STREET CORP3.8M$1.96Bincreased
Invesco Ltd.3.4M$1.76Bdecreased
GEODE CAPITAL MANAGEMENT, LLC2.6M$1.37Bincreased
BAMCO INC /NY/1.8M$930.8Mdecreased
MORGAN STANLEY1.4M$717.7Mincreased
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.4M$709.9Mincreased
GOLDMAN SACHS GROUP INC1.2M$614.4Mincreased
T. Rowe Price Investment Management, Inc.1.0M$539.8Mincreased
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1.0M$539.4Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by IDXX insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: -13.0K2025 Q12025 Q2: -6,2682025 Q22025 Q3: -54.1K2025 Q32025 Q4: -9,4252025 Q42026 Q1: -46.0K2026 Q12026 Q2: 02026 Q22026 Q3: -2,2032026 Q32026 Q4: -39.2K2026 Q4

Recent Insider Transactions

3,011 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Underberg Sharon E.EVP, GC & Corporate Secretary Sale −6,348 $688.25 $4.4M Nov 4, 2026 Form 4 ↗
Underberg Sharon E.EVP, GC & Corporate Secretary Sale −1,503 $689.05 $1.0M Nov 4, 2026 Form 4 ↗
Underberg Sharon E.EVP, GC & Corporate Secretary Sale −1,055 $690.02 $728K Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −840 $707.00 $594K Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −775 $711.31 $551K Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −4,540 $701.36 $3.2M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −4,075 $699.33 $2.8M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −3,950 $703.45 $2.8M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −331 $711.95 $236K Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −240 $705.59 $169K Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −2,136 $702.21 $1.5M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −1,945 $698.26 $1.4M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −1,840 $707.84 $1.3M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −1,667 $700.33 $1.2M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −1,501 $710.12 $1.1M Nov 4, 2026 Form 4 ↗
MAZELSKY JONATHAN JAYExecutive Chair of the Board · Director Sale −1,300 $709.00 $922K Nov 4, 2026 Form 4 ↗
Lane MichaelExecutive Vice President Sale −243 $687.85 $167K Nov 4, 2026 Form 4 ↗
Lane MichaelExecutive Vice President Sale −2,059 $689.70 $1.4M Nov 4, 2026 Form 4 ↗
Lane MichaelExecutive Vice President Sale −1,677 $687.46 $1.2M Nov 4, 2026 Form 4 ↗
JUNIUS DANIEL MDirector · Director Sale −700 $705.78 $494K Nov 4, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding IDXX · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.5M$1.32B0.06%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
2.0M$1.08B0.06%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.7M$899.8M0.40%Jun 30, 2026
Invesco QQQ Trust, Series 11.7M$881.5M0.18%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
1.1M$571.3M0.06%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
1.0M$570.0M0.07%Aug 31, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust956.2K$503.4M0.06%Jun 30, 2026
VANGUARD GROWTH INDEX FUND
VANGUARD INDEX FUNDS
942.3K$496.1M0.13%Jun 30, 2026
Baron Partners Fund
BARON SELECT FUNDS
846.3K$445.5M2.47%Jun 30, 2026
AMCAP Fund732.9K$408.0M0.43%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list IDXX's shares (CUSIP 45168D104), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Vanguard Portfolio ManagementSCHEDULE 13G · passive (13G) · 4.0M shares5.0%
    Oct 30, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming IDEXX LABORATORIES INC /DE as client

No lobbying filings found naming IDEXX LABORATORIES INC /DE as the client.

Government Contracts

Federal awards to idexx laboratories · USAspending
$112KAwarded · 21 contracts on record
  • Department of Defense8509926115!WATER SAMPLING TEST KIT$326
    Jun 1, 2023 · ↗
  • Department of Defense8509588903!COMPARATOR,COLOR$12
    Dec 14, 2022 · ↗
  • Department of Defense8509814633!COMPARATOR,COLOR$12
    Apr 6, 2023 · ↗
  • Department of Defense8509658334!COMPARATOR,COLOR$12
    Jan 24, 2023 · ↗
  • Department of Defense8509814622!COMPARATOR,COLOR$12
    Apr 6, 2023 · ↗
  • Department of Defense8509748540!COMPARATOR,COLOR$47
    Mar 8, 2023 · ↗
  • Department of Defense8509833519!WATER SAMPLING TEST$315
    Apr 14, 2023 · ↗
  • Department of Health and Human ServicesDVMAX ANNUAL SUPPORT FEE$15K
    Sep 15, 2020 · ↗

U.S. Patents

Recent USPTO applications naming IDEXX LABORATORIES INC /DE

No USPTO patent applications found for IDEXX LABORATORIES INC /DE.

Annual Financials

From IDXX's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$4.30B$3.90B$3.66B$3.37B$3.22B
Operating income$1.36B$1.13B$1.10B$898.8M$932.0M
Net income$1.06B$887.9M$845.0M$679.1M$744.8M
Diluted EPS$13.08$10.67$10.06$8.03$8.60
Operating cash flow$1.18B$929.0M$906.5M$543.0M$755.5M
Cash and equivalents$180.1M$288.3M$453.9M$112.5M$144.5M
Total assets$3.35B$3.29B$3.26B$2.75B$2.44B
Total liabilities$1.75B$1.70B$1.78B$2.14B$1.75B
Shareholders' equity$1.61B$1.60B$1.48B$608.7M$690.0M

As IDEXX LABORATORIES INC /DE tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 20, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitJun 16, 2015
  • 2-for-1Stock splitNov 27, 2007
  • 2-for-1Stock splitJun 6, 1995
  • 2-for-1Stock splitOct 4, 1993

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 2, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
    EDGAR ↗
  • 8-K · Items 5.03, 5.07, 9.01Bylaw amendment · Shareholder voteMay 15, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
    EDGAR ↗

About IDEXX LABORATORIES INC /DE

From SEC EDGAR company records
Industry (SIC 2835)In Vitro & In Vivo Diagnostic Substances
SectorHealthcare
HeadquartersWESTBROOK, ME
IncorporatedDE